| Product Code: ETC13153396 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Malaria Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Malaria Vaccine Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Malaria Vaccine Market - Industry Life Cycle |
3.4 Africa Malaria Vaccine Market - Porter's Five Forces |
3.5 Africa Malaria Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Africa Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.8 Africa Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Africa Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Africa Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Malaria Vaccine Market Trends |
6 Africa Malaria Vaccine Market, 2021 - 2031 |
6.1 Africa Malaria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Malaria Vaccine Market, Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021 - 2031 |
6.1.3 Africa Malaria Vaccine Market, Revenues & Volume, By Erythrocytic Vaccine, 2021 - 2031 |
6.1.4 Africa Malaria Vaccine Market, Revenues & Volume, By Multi-Antigen Vaccine, 2021 - 2031 |
6.2 Africa Malaria Vaccine Market, Revenues & Volume, By Agent, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Malaria Vaccine Market, Revenues & Volume, By Plasmodium Falciparum, 2021 - 2031 |
6.2.3 Africa Malaria Vaccine Market, Revenues & Volume, By Plasmodium Vivax, 2021 - 2031 |
6.2.4 Africa Malaria Vaccine Market, Revenues & Volume, By Anopheles Species, 2021 - 2031 |
6.3 Africa Malaria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Malaria Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.3.3 Africa Malaria Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.3.4 Africa Malaria Vaccine Market, Revenues & Volume, By Intradermal, 2021 - 2031 |
6.4 Africa Malaria Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Malaria Vaccine Market, Revenues & Volume, By NGO/Non-Profit Organization, 2021 - 2031 |
6.4.3 Africa Malaria Vaccine Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.4.4 Africa Malaria Vaccine Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.4.5 Africa Malaria Vaccine Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
7 Africa Malaria Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Malaria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 South Africa Malaria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 Egypt Malaria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Nigeria Malaria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Rest of Africa Malaria Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Africa Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
7.3.1 South Africa Malaria Vaccine Market, Revenues & Volume, By Agent, 2021 - 2031 |
7.3.2 Egypt Malaria Vaccine Market, Revenues & Volume, By Agent, 2021 - 2031 |
7.3.3 Nigeria Malaria Vaccine Market, Revenues & Volume, By Agent, 2021 - 2031 |
7.3.4 Rest of Africa Malaria Vaccine Market, Revenues & Volume, By Agent, 2021 - 2031 |
7.4 Africa Malaria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.1 South Africa Malaria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.2 Egypt Malaria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.3 Nigeria Malaria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.4.4 Rest of Africa Malaria Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 Africa Malaria Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 South Africa Malaria Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Egypt Malaria Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Nigeria Malaria Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.4 Rest of Africa Malaria Vaccine Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Africa Malaria Vaccine Market Key Performance Indicators |
9 Africa Malaria Vaccine Market - Export/Import By Countries Assessment |
10 Africa Malaria Vaccine Market - Opportunity Assessment |
10.1 Africa Malaria Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Africa Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
10.4 Africa Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.5 Africa Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 Africa Malaria Vaccine Market - Competitive Landscape |
11.1 Africa Malaria Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Africa Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here